Sivik Global Healthcare’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,755
| Closed | -$1.25M | – | 44 |
|
|
2022
Q3 | $1.25M | Buy |
+18,755
| New | +$1.39M | 0.69% | 39 |
|
|
2022
Q2 | – | Sell |
-35,000
| Closed | -$2.78M | – | 46 |
|
|
2022
Q1 | $2.78M | Buy |
+35,000
| New | +$2.55M | 1.15% | 41 |
|
|
2021
Q1 | – | Sell |
-60,000
| Closed | -$5.22M | – | 53 |
|
|
2020
Q4 | $5.22M | Buy |
+60,000
| New | +$5.19M | 2.13% | 28 |
|
|
2020
Q3 | – | Sell |
-100,000
| Closed | -$9.29M | – | 53 |
|
|
2020
Q2 | $9.29M | Sell |
100,000
-15,000
| -13% | -$1.45M | 3.08% | 11 |
|
|
2020
Q1 | $11.4M | Buy |
115,000
+75,000
| +188% | +$5.67M | 4.5% | 4 |
|
|
2019
Q4 | $3.49M | Sell |
40,000
-15,000
| -27% | -$1.28M | 1.3% | 38 |
|
|
2019
Q3 | $4.08M | Buy |
55,000
+10,000
| +22% | +$808K | 2.06% | 27 |
|
|
2019
Q2 | $3.82M | Sell |
45,000
-15,000
| -25% | -$1.2M | 0.92% | 32 |
|
|
2019
Q1 | $5.16M | Buy |
60,000
+25,000
| +71% | +$2.03M | 1.9% | 25 |
|
|
2018
Q4 | $2.23M | Sell |
35,000
-5,000
| -13% | -$325K | 1.2% | 36 |
|
|
2018
Q3 | $2.76M | Sell |
40,000
-45,000
| -53% | -$3.09M | 0.99% | 43 |
|
|
2018
Q2 | $5.7M | Buy |
85,000
+40,000
| +89% | +$2.74M | 2.19% | 21 |
|
|
2018
Q1 | $3.75M | Sell |
45,000
-25,000
| -36% | -$2.25M | 1.75% | 26 |
|
|
2017
Q4 | $6.63M | Buy |
70,000
+25,000
| +56% | +$2.61M | 2.46% | 10 |
|
|
2017
Q3 | $5.25M | Sell |
45,000
-15,000
| -25% | -$1.9M | 1.79% | 24 |
|
|
2017
Q2 | $7.55M | Buy |
60,000
+10,000
| +20% | +$1.27M | 2.77% | 7 |
|
|
2017
Q1 | $6.68M | Sell |
50,000
-5,000
| -9% | -$637K | 3.11% | 8 |
|
|
2016
Q4 | $5.51M | Sell |
55,000
-5,000
| -8% | -$488K | 2.63% | 16 |
|
|
2016
Q3 | $5.66M | Buy |
60,000
+25,000
| +71% | +$2.11M | 2.85% | 14 |
|
|
2016
Q2 | $2.8M | Buy |
35,000
+5,000
| +17% | +$388K | 1.39% | 38 |
|
|
2016
Q1 | $2.17M | Buy |
30,000
+307
| +1% | +$22.9K | 0.96% | 42 |
|
|
2015
Q4 | $3.22M | Buy |
29,693
+2,693
| +10% | +$300K | 1.53% | 31 |
|
|
2015
Q3 | $2.98M | Hold |
27,000
| – | – | 1.44% | 28 |
|
|
2015
Q2 | $2.81M | Sell |
27,000
-7,700
| -22% | -$797K | 0.98% | 41 |
|
|
2015
Q1 | $3.18M | Hold |
34,700
| – | – | 1.08% | 42 |
|
|
2014
Q4 | $2.54M | Buy |
34,700
+9,700
| +39% | +$634K | 1.03% | 49 |
|
|
2014
Q3 | $1.23M | Buy |
+25,000
| New | +$1.25M | 0.56% | 59 |
|
|
2014
Q2 | – | Sell |
-24,750
| Closed | -$1.32M | – | 76 |
|
|
2014
Q1 | $1.32M | Buy |
24,750
+9,750
| +65% | +$605K | 0.83% | 52 |
|
|
2013
Q4 | $759K | Buy |
+15,000
| New | +$653K | 0.54% | 54 |
|
Other funds holding INCY
BBA
Sivik Global Healthcare's INCY Position: Q4 2022 in Review
Sivik Global Healthcare sold out of Incyte (INCY) in Q4 2022, closing a stake of 18,755 shares — an estimated $1.25M sold.
Sivik Global Healthcare first reported a position in INCY in Q4 2013 and held it in 29 quarters. The position peaked at $11.4M in Q1 2020. 559 funds tracked by Wall St. Rank hold INCY as of Q4 2022.
- Sivik Global Healthcare reported no remaining Incyte position as of Q4 2022 after selling out during the quarter.
- Sivik Global Healthcare sold 18,755 Incyte shares in Q4 2022, an estimated $1.25M.
- Sivik Global Healthcare first reported a position in Incyte in Q4 2013 and held it in 29 quarters.
- Sivik Global Healthcare's Incyte position peaked at $11.4M in Q1 2020.
- 559 funds tracked by Wall St. Rank held Incyte as of Q4 2022.
Based on Sivik Global Healthcare's 13F filing for Q4 2022, filed 8 Feb 2023.